BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$227.53

+2.17 (+0.96%)

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 30 70%

Hold 12 28%

Sell 1 2%

Price Target

Analyst Price Target -59.8% upside

Low Target $57.23

Average Target $91.45

High Target $114.90

Current Price $227.53

Current
$227.53

Target
$91.45

$57.23 $91.45 avg $114.90

Scenario Analysis

Bear Case

$57.23

-74.8%

Low target

Base Case

$91.45

-59.8%

Avg target

Bull Case

$114.90

+-49.5%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$225.80

0.8% from high

52-Week Low

$135.39

+68.1% from low

50-Day SMA

$179.51

+26.8% vs SMA

200-Day SMA

$150.33

+51.4% vs SMA

RSI (14)

64.3

Neutral

Target vs 52W High

$91.45

-59.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%